Pan-cancer survival analysis ground on the TCGA database was implemented to evaluate the predictive value and clinical significance of LETM2, which represented that elevated expression of LETM2 was most significantly associated with dismal prognosis of pancreatic cancer, either poor OS or DFS. Here, LETM2 is linked to pancreatic neoplasm.